Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,127.99
(
-0.70%
)
News Focus
News Focus
Post# of 185027
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TheFinalCD

Send PM Follow Ignore
Followers 4045
Posts 152977
Boards Moderated 3
Alias Born 08/05/2009

TheFinalCD

Member Level

Re: ~MulaGreen~ post# 86012

Wednesday, 12/06/2017 11:02:55 AM

Wednesday, December 06, 2017 11:02:55 AM

Post# of 185027
Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients with Biopsy-proven Non-alcoholic Steatohepatitis (NASH) in Phase 2 Clinical Trial

https://finance.yahoo.com/news/madrigal-mgl-3196-achieves-primary-115500496.html

why couldnt we have 1-2k of this premarket

$54-$101



l;ol


Always consult an Investment Professional, my posts are my own
opinions, and not for investing decisions~!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today